![Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire](https://mms.businesswire.com/media/20220304005319/en/739014/22/teva_RGB_JPEG.jpg)
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire
![Teva shutters New York, D.C. offices and dismisses lobbyists as part of U.S. consolidation drive | Fierce Pharma Teva shutters New York, D.C. offices and dismisses lobbyists as part of U.S. consolidation drive | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1519392364/teva1_1.jpg/teva1_1.jpg?VersionId=9yks0beA2l1CvdFeI0kPQH3NmrgKCHKU)
Teva shutters New York, D.C. offices and dismisses lobbyists as part of U.S. consolidation drive | Fierce Pharma
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
![Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal](https://media.bizj.us/view/img/6047051/img0195*1024xx2490-1403-0-608.jpg)